Table 1 Comparison of characteristics of the two groups
Characteristic | Nab-TC (n = 40) | TC (n = 40) | Statistics | P value |
|---|---|---|---|---|
Number (percent) | ||||
Age (years) | χ2 = 1.805 | 0.179 | ||
> 53 | 16 (40) | 22 (55) | ||
≤ 53 | 24 (60) | 18 (45) | ||
PS | χ2 = 0.000 | 1.000 | ||
0 | 16 (40) | 16 (40) | ||
1 | 24 (60) | 24 (60) | ||
FIGO stage | χ2 = 0.346 | 0.556 | ||
III | 34 (85) | 32 (80) | ||
IV | 6 (15) | 8 (20) | ||
CA-125 value (U/mL) | χ2 = 0.800 | 0.371 | ||
> 672 | 18 (45) | 22 (55) | ||
≤ 672 | 22 (55) | 18 (45) | ||
> 100 | 40 (100) | 38 (95) | 0.494 | |
≤ 100 | 0 (0) | 2 (5) | ||
Pathological type | – | 1.000 | ||
Serous cystadenocarcinoma | 40 (100) | 40 (100) | ||
Mean number ± SD | ||||
BMI | 24.16 ± 5.159 | 23.04 ± 3.495 | t = −1.140 | 0.258 |
NAC cycles | 2.25 ± 0.899 | 2.05 ± 0.986 | t = −0.948 | 0.346 |
Total cycles | 6.35 ± 1.122 | 7.00 ± 0.906 | t = 2.851 | 0.006 |